Use of a tyrosine kinase inhibitor as neoadjuvant therapy for non-small cell lung cancer: A case report

We report here a 66-year-old woman diagnosed with bronchioloalveolar carcinoma of the right lung cT4N2M0. The patient was from the Philippines, had never smoked, and tested positive for an EGFR mutation. She received gefitinib as neoadjuvant therapy for two months and displayed a partial response. T...

Descripción completa

Detalles Bibliográficos
Autores principales: López-González, A., Almagro, E., Salas, C., Varela, A., Provencio, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3949555/
https://www.ncbi.nlm.nih.gov/pubmed/26029620
http://dx.doi.org/10.1016/j.rmcr.2013.02.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3949555/
https://www.ncbi.nlm.nih.gov/pubmed/26029620
http://dx.doi.org/10.1016/j.rmcr.2013.02.002

Ejemplares similares